Jacobs Levy Equity Management Inc. boosted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 645,662 shares of the biopharmaceutical company’s stock after acquiring an additional 109,676 shares during the quarter. Jacobs […]